Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Brindle (Hull, United Kingdom), R. Thompson (Hull, United Kingdom), C. Wright (Hull, United Kingdom), T. Cavany (Hull, United Kingdom), D. Ingram (Hull, United Kingdom), M. Robinson (Hull, United Kingdom), A. Morice (Hull, United Kingdom). The use of objective 24 hour cough monitoring to measure clinical improvement in cystic fibrosis.. 1940

Member's Comments

No comment yet.

Related content which might interest you: Is impulse oscillometry (IOS) better than spirometry for monitoring treatment outcomes in adult cystic fibrosis (CF) pulmonary exacerbations? A pilot study Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 The value of lung function monitoring by means of a home monitor in patients with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation Year: 2011 Feasibility study of an intervention to increase treatment adherence in children with cystic fibrosis (CF) Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 Usefulness of web transmission of overnight recording of SaO2 and daily FEV1 in the early diagnosis of pulmonary exacerbations in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 529s Year: 2002 The concept of cystic fibrosis pulmonary exacerbation in clinical medicine and as a trial end-point Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art Year: 2008 An increase in steps per day 6 weeks after pulmonary rehabilitation of COPD patients correlates with an improvement in quality of life Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 Change in functional lung MRI and multiple breath washout outcomes over one year in children with cystic fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Denufosol targets small airways and elicits meaningful improvements in mild cystic fibrosis (CF) patients on minimal pharmacotherapy Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections Year: 2010 The effect of spirometry on multiple breath washout outcomes in children with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 6 and 12 month outcomes following RePneu bronchoscopic lung volume reduction coil treatment Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going? Year: 2013 18FDG-PET imaging detects inflammatory changes in pediatric cystic fibrosis patients after treatment for a pulmonary exacerbation Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections Year: 2010 COPD: problems in diagnosis and measurement Source: Eur Respir J 2003; 21: 4S-12S Year: 2003 Analysis of the daily symptom profile of patients with non-cystic fibrosis bronchiectasis (NCFB) using a symptom diary. Source: Virtual Congress 2021 – Bronchiectasis and pleural infection Year: 2021 Should use of 4 hours continuous positive airway pressure per night be considered acceptable compliance? Source: Eur Respir J 2014; 44: 1119-1120 Year: 2014 A simple assessment of dyspnea as a prognostic indicator in idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF) Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology Year: 2008 Comparison of exercise capacity, physical activity level and quality of life in patients with different severity of non-cystic fibrosis bronchiectasis> Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021 24 hour versus early morning spontaneous sputum collection for routine microbiology in stable bronchiectasis Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 CFTR biomarkers: time for promotion to surrogate end-point Source: Eur Respir J 2013; 41: 203-216 Year: 2013